Hemab Therapeutics Announces that the First Participant Has Accepted the First Phase of Clinical Trials for Hmb-003
2026-09-17 20:01:21
According to CoinMeta, as reported by Reuters, Hemab Therapeutics announced that the first participant has enrolled in the first phase of clinical trials for Hmb-003, a therapy designed to manage severe menstrual bleeding.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.